Artal Group S.A. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$5,874
-43.2%
2,046,5170.0%0.25%
-21.2%
Q2 2023$10,335
+232.1%
2,046,517
+24.3%
0.32%
+73.0%
Q1 2023$3,112
+5.0%
1,646,5170.0%0.18%
+12.1%
Q4 2022$2,964
-99.9%
1,646,5170.0%0.16%
+38.7%
Q3 2022$2,783,000
-31.3%
1,646,5170.0%0.12%
-44.9%
Q2 2022$4,050,000
-11.2%
1,646,5170.0%0.22%
+13.1%
Q1 2022$4,561,000
-48.0%
1,646,5170.0%0.19%
-19.7%
Q4 2021$8,776,000
-37.0%
1,646,5170.0%0.24%
-23.7%
Q3 2021$13,930,000
-30.6%
1,646,5170.0%0.31%
-23.3%
Q2 2021$20,071,000
-49.8%
1,646,5170.0%0.41%
-42.4%
Q1 2021$39,945,000
-24.3%
1,646,5170.0%0.71%
-37.7%
Q4 2020$52,771,000
+14.7%
1,646,517
+8.2%
1.13%
+1.4%
Q3 2020$45,995,000
-29.5%
1,521,517
-1.6%
1.12%
-38.8%
Q2 2020$65,201,000
+54.0%
1,546,517
-8.8%
1.82%
+2.0%
Q1 2020$42,328,0001,696,5171.79%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders